COMPANY PROFILE // THE 014 REPORT
RenovoRx, Inc.
RNXT (Nasdaq)
Assembled from 2 government sources in 0.1 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
- Amber8-K Item 3.01 filed: notice of delisting, of a failed continued-listing rule, or of a transfer of listing on 2026-07-02 and 1 more time (last 24 months).
- AmberNT 10-K filed on 2025-03-31: notice that a periodic report would be late.
✓ SEC filings✗ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.
RenovoRx, Inc. is an SEC-registered operating company in surgical & medical instruments & apparatus, incorporated in DE, based in Mountain View, CA; listed as RNXT (Nasdaq).[source] It reported revenue of $1.1 million for the fiscal year ended 2025-12-31.[source] It has filed 57 documents with the SEC in the last 12 months; the latest is Form 4, filed 2026-11-17.[source] Its largest institutional holders on 13F filings are AIGH Capital Management LLC, Bleichroeder LP, VANGUARD CAPITAL MANAGEMENT LLC (as of 2026-06-30).[source] Seraphix flags 2 items from these records: 8-K Item 3.01 filed; NT 10-K filed on 2025-03-31.[source]
- red0
- amber2
- info0
- AIGH Capital Management LLC$4.3M
- Bleichroeder LP$1.6M
- VANGUARD CAPITAL MANAGEMENT LLC$1.4M
- GEODE CAPITAL MANAGEMENT, LLC$416K
- Wealthspire Advisors, LLC$247K
- VANGUARD FIDUCIARY TRUST CO$236K
- CITADEL ADVISORS LLC$131K
- NORTHERN TRUST CORP$84K
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Officers and directors (Forms 3, 4, 5)
- Agah Ramtin · Chief Medical Officer (Director,Officer) · latest Form 4 2026-01-22 · filing · LinkedIn search
- Bagai Shaun · Chief Executive Officer (Director,Officer) · latest Form 4 2026-03-24 · filing · LinkedIn search
- Gentry Leesa · Chief Clinical Officer (Officer) · latest Form 4 2025-07-03 · filing · LinkedIn search
- Kocak Ron · VP, Controller and PAO (Officer) · latest Form 4 2025-07-03 · filing · LinkedIn search
- VOLL MARK · Chief Financial Officer (Officer) · latest Form 4 2026-03-27 · filing · LinkedIn search
- Macfarlane K. Angela · Director · latest Form 4 2025-10-02 · filing · LinkedIn search
- Marton Laurence · Director · latest Form 4 2026-03-24 · filing · LinkedIn search
- RYAN UNA S · Director · latest Form 4 2025-10-02 · filing · LinkedIn search
- Spiegel Robert J. · Director · latest Form 4 2025-10-02 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0001574094 | source |
| EIN | 27-1448452 | source |
| Business address (SEC) | 2570 W. EL CAMINO REAL, STE. 320,, MOUNTAIN VIEW, CA, 94040 | source |
Does not exist in the records we hold: LEI, UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-03-31 · in 131 days · Next 10-K due (period ended 2026-12-31; Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company) (computed from the fiscal year end and filer status)
- 2027-05-15 · in 176 days · Next 10-Q due (period ended 2027-03-31; Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 3841 (surgical & medical instruments & apparatus): 149 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- STRYKER CORP · 101 SEC filings in 12 months · 1 flag · $502.2M federal (possible match)
- ORASURE TECHNOLOGIES INC · 69 SEC filings in 12 months · 2 flags · $480.7M federal (possible match)
- 3M CO · 124 SEC filings in 12 months · $465.5M federal (possible match)
- BOSTON SCIENTIFIC CORP · 110 SEC filings in 12 months · 1 flag · $140.1M federal (possible match)
- CERUS CORP · 71 SEC filings in 12 months · 2 flags · $126.6M federal (possible match)
- BAXTER INTERNATIONAL INC · 84 SEC filings in 12 months · 1 flag · $54.7M federal (possible match)
- Inspire Medical Systems, Inc. · 100 SEC filings in 12 months · 4 flags · $22.3M federal (possible match)
- ACCURAY INC · 103 SEC filings in 12 months · 4 flags · $13.9M federal (possible match)
- NeuroPace Inc · 61 SEC filings in 12 months · $10.3M federal (possible match)
- TELEFLEX INC · 64 SEC filings in 12 months · 1 flag · $9.4M federal (possible match)
- Cytosorbents Corp · 30 SEC filings in 12 months · 4 flags · $5.0M federal (possible match)
- IRADIMED CORP · 70 SEC filings in 12 months · 1 flag · $4.0M federal (possible match)
ADDRESS · ZIP CODE
Location context
At the same address (2)
- SHAAR EDUCATION · IRS-registered organization
SHARED PEOPLE · SHARED ADDRESS
Network neighbours
Shared directors and officers
- IRulya Therapeutics Inc. · RYAN UNA S
- GERON CORP · Spiegel Robert J.
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-11-05 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-11-05 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-10-16 filing RW · SEC EDGAR
- 2026-08-20 filing 8-K items 8.01 · SEC EDGAR
- 2026-08-13 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-08-13 filing 8-K/A items 2.02,9.01 · SEC EDGAR
- 2026-08-12 filing 8-K items 9.01 · SEC EDGAR
- 2026-08-04 filing 8-K items 8.01,9.01 · SEC EDGAR
- 2026-07-02 filing 8-K items 3.01 · SEC EDGAR
- 2026-06-30 filing S-8 · SEC EDGAR
- 2026-06-30 filing 8-K items 5.07,9.01 · SEC EDGAR
- 2026-05-15 filing 10-K/A · SEC EDGAR
- 2026-05-14 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-05-14 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-04-30 filing Proxy statement · SEC EDGAR
- 2026-04-27 filing EFFECT · SEC EDGAR
- 2026-04-27 filing 424B3 · SEC EDGAR
- 2026-04-23 filing CORRESP · SEC EDGAR
- 2026-04-22 filing UPLOAD · SEC EDGAR
- 2026-04-16 filing S-3 · SEC EDGAR
- 2026-04-09 filing D · SEC EDGAR
- 2026-03-31 filing S-8 · SEC EDGAR
- 2026-03-30 filing 8-K items 2.02,8.01,9.01 · SEC EDGAR
- 2026-03-30 filing Annual report (10-K) · SEC EDGAR
- 2026-03-27 filing 3/A · SEC EDGAR
- 2026-03-27 officer change 8-K items 5.02,9.01 · SEC EDGAR
- 2026-03-24 insider First Form 3/4/5 on record for VOLL MARK (Chief Financial Officer) · SEC Forms 3/4/5
- 2026-03-23 filing 8-K items 1.01,3.02,8.01,9.01 · SEC EDGAR
- 2026-02-06 officer change 8-K items 5.02,8.01,9.01 · SEC EDGAR
- 2026-01-02 filing 8-K items 3.01 · SEC EDGAR
150 earlier entries
- 2025-11-14 filing 8-K items 1.01,9.01
- 2025-11-14 filing 424B5
- 2025-11-14 filing S-3
- 2025-11-13 filing 8-K items 2.02,8.01,9.01
- 2025-11-13 filing Quarterly report (10-Q)
- 2025-10-02 insider First Form 3/4/5 on record for Macfarlane K. Angela (Director)
- 2025-10-02 insider First Form 3/4/5 on record for RYAN UNA S (Director)
- 2025-10-02 insider First Form 3/4/5 on record for Spiegel Robert J. (Director)
- 2025-08-28 filing UPLOAD
- 2025-08-14 filing 8-K items 2.02,8.01,9.01
- 2025-08-14 filing Quarterly report (10-Q)
- 2025-08-13 filing CORRESP
- 2025-07-29 filing UPLOAD
- 2025-07-18 filing CORRESP
- 2025-07-10 filing UPLOAD
- 2025-06-27 filing S-8
- 2025-06-25 filing 8-K items 5.07
- 2025-05-15 filing Quarterly report (10-Q)
- 2025-05-15 filing 8-K items 2.02,8.01,9.01
- 2025-04-30 filing Proxy statement
- 2025-04-16 insider First Form 3/4/5 on record for Gentry Leesa (Chief Clinical Officer)
- 2025-04-10 insider First Form 3/4/5 on record for Kocak Ron (VP, Controller and PAO)
- 2025-04-09 insider First Form 3/4/5 on record for Agah Ramtin (Chief Medical Officer)
- 2025-04-09 insider First Form 3/4/5 on record for Marton Laurence (Director)
- 2025-04-08 insider First Form 3/4/5 on record for Bagai Shaun (Chief Executive Officer)
- 2025-04-01 filing 8-K items 2.02,8.01,9.01
- 2025-04-01 filing Annual report (10-K)
- 2025-03-31 filing NT 10-K
- 2025-02-10 filing 8-K items 1.01,8.01,9.01
- 2025-02-10 filing 424B5
- 2025-02-06 filing 424B5
- 2024-11-14 filing 8-K items 2.02,9.01
- 2024-11-13 filing Quarterly report (10-Q)
- 2024-09-25 filing 8-K items 8.01,9.01
- 2024-08-16 filing 8-K items 4.01
- 2024-08-13 filing Quarterly report (10-Q)
- 2024-06-07 officer change 8-K items 5.02,5.07,9.01
- 2024-05-10 filing EFFECT
- 2024-05-10 filing EFFECT
- 2024-05-10 filing Quarterly report (10-Q)
- 2024-05-10 filing 424B3
- 2024-05-10 filing 424B3
- 2024-05-08 filing CORRESP
- 2024-05-08 filing CORRESP
- 2024-05-03 officer change 8-K items 4.01,5.02,9.01
- 2024-05-01 filing UPLOAD
- 2024-04-30 filing Proxy statement
- 2024-04-26 filing S-3
- 2024-04-24 filing UPLOAD
- 2024-04-22 filing D
- 2024-04-19 filing S-3
- 2024-04-18 filing 8-K items 8.01,9.01
- 2024-04-16 filing 8-K items 8.01
- 2024-04-15 filing 8-K items 3.02,7.01,8.01,9.01
- 2024-04-12 filing S-8
- 2024-04-09 filing 8-K items 1.01,8.01,9.01
- 2024-04-01 filing Annual report (10-K)
- 2024-03-14 officer change 8-K items 5.02,9.01
- 2024-02-23 officer change 8-K items 3.01,5.02
- 2024-02-09 officer change 8-K items 5.02,9.01
- 2024-02-09 filing D
- 2024-01-29 officer change 8-K items 1.01,5.02,7.01,9.01
- 2024-01-02 filing 8-K items 8.01
- 2023-12-18 filing 8-K items 5.07
- 2023-11-27 filing Proxy statement
- 2023-11-17 filing PRE 14A
- 2023-11-14 filing 8-K items 2.02,9.01
- 2023-11-13 filing Quarterly report (10-Q)
- 2023-11-06 filing 8-K items 8.01
- 2023-09-11 filing 8-K items 5.03,8.01,9.01
- 2023-08-25 filing 8-K items 3.01
- 2023-08-17 filing 8-K items 2.02,9.01
- 2023-08-16 filing Quarterly report (10-Q)
- 2023-08-15 filing NT 10-Q
- 2023-06-29 filing 8-K items 8.01,9.01
- 2023-06-09 filing 8-K items 5.07
- 2023-05-19 filing EFFECT
- 2023-05-19 filing 424B3
- 2023-05-17 filing CORRESP
- 2023-05-16 filing UPLOAD
- 2023-05-15 filing 8-K items 2.02,9.01
- 2023-05-12 filing S-3
- 2023-05-12 filing Quarterly report (10-Q)
- 2023-05-01 filing Proxy statement
- 2023-04-27 officer change 8-K items 5.02,9.01
- 2023-04-03 filing 8-K items 1.01,3.02,8.01,9.01
- 2023-04-03 filing 424B5
- 2023-04-03 filing S-8 POS
- 2023-03-31 filing S-8
- 2023-03-31 filing Annual report (10-K)
- 2023-03-02 filing 8-K items 2.02,8.01,9.01
- 2023-01-18 filing 8-K items 8.01,9.01
- 2022-11-22 filing 424B3
- 2022-11-21 filing EFFECT
- 2022-11-21 filing EFFECT
- 2022-11-18 filing CORRESP
- 2022-11-18 filing CORRESP
- 2022-11-16 filing UPLOAD
- 2022-11-16 filing UPLOAD
- 2022-11-14 filing 8-K items 2.02,9.01
- 2022-11-14 filing Quarterly report (10-Q)
- 2022-11-10 filing Registration (S-1)
- 2022-11-10 filing S-3
- 2022-09-19 officer change 8-K items 5.02,7.01,9.01
- 2022-08-15 filing 8-K items 2.02,9.01
- 2022-08-12 filing Quarterly report (10-Q)
- 2022-07-19 officer change 8-K items 5.02,7.01,9.01
- 2022-06-17 filing 3/A
- 2022-06-09 filing 8-K items 5.07
- 2022-05-16 filing 8-K items 2.02,9.01
- 2022-05-13 filing Quarterly report (10-Q)
- 2022-04-29 filing Proxy statement
- 2022-03-30 filing S-8
- 2022-03-30 filing 8-K items 2.02,7.01,9.01
- 2022-03-30 filing Annual report (10-K)
- 2021-12-10 filing 8-K items 4.01,9.01
- 2021-11-15 filing 8-K items 2.02,9.01
- 2021-11-15 filing Quarterly report (10-Q)
- 2021-10-29 filing S-8
- 2021-08-31 filing 8-K items 5.03,9.01
- 2021-08-27 filing 424B4
- 2021-08-25 filing EFFECT
- 2021-08-25 filing CORRESP
- 2021-08-25 filing CORRESP
- 2021-08-25 filing S-1/A
- 2021-08-24 filing CORRESP
- 2021-08-24 filing CERT
- 2021-08-20 filing CORRESP
- 2021-08-20 filing CORRESP
- 2021-08-19 filing S-1/A
- 2021-08-12 filing CORRESP
- 2021-08-12 filing S-1/A
- 2021-08-11 filing 8-A12B
- 2021-08-10 filing CORRESP
- 2021-08-10 filing CORRESP
- 2021-08-05 filing S-1/A
- 2021-08-05 filing CORRESP
- 2021-07-29 filing UPLOAD
- 2021-07-21 filing Registration (S-1)
- 2021-06-15 filing DRSLTR
- 2021-06-15 filing DRS/A
- 2021-05-28 filing UPLOAD
- 2021-05-12 filing DRSLTR
- 2021-05-12 filing DRS/A
- 2021-05-03 filing UPLOAD
- 2021-04-02 filing DRS
- 2018-06-19 filing D
- 2016-01-05 filing D
- 2013-12-23 filing D
- 2013-04-10 filing D
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-11-05 (within 30 days) 10-Q filed
- 2026-11-05 (within 30 days) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-10-16 (older) RW filed
- 2026-08-20 (older) 8-K filed: Item 8.01 other event
- 2026-08-13 (older) 10-Q filed
- 2026-08-13 (older) 8-K/A filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-08-12 (older) 8-K filed: Item 9.01 exhibits
- 2026-08-04 (older) 8-K filed: Item 8.01 other event; Item 9.01 exhibits
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-20; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:RNXT The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
1 possible match held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 1574094 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | RNXT / Nasdaq | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| EIN | 271448452 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001574094 | SEC EDGAR / IRS |
| CUSIP | 75989R107 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001574094 | SEC EDGAR |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Revenue (fiscal year ended 2025-12-31) | $1,123,000 | 2025-12-31 | 10-K, XBRL Revenues | as filed | 2026-11-20 07:29 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | -$11,168,000 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-20 07:29 UTC | Report an error |
| Total assets (at 2025-12-31) | $8,095,000 | 2025-12-31 | 10-K, XBRL Assets | as filed | 2026-11-20 07:29 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $5,422,000 | 2025-12-31 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-20 07:29 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $7,024,000 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-20 07:29 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-17 | SEC EDGAR company profile | as filed | 2026-11-20 07:29 UTC | Report an error |
| SIC industry | 3841 Surgical & Medical Instruments & Apparatus | 2026-11-17 | SEC EDGAR company profile | as filed | 2026-11-20 07:29 UTC | Report an error |
| State of incorporation | DE | 2026-11-17 | SEC EDGAR company profile | as filed | 2026-11-20 07:29 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-17 | SEC EDGAR company profile | as filed | 2026-11-20 07:29 UTC | Report an error |
| Business address | 2570 W. EL CAMINO REAL, STE. 320,, MOUNTAIN VIEW, CA, 94040 | 2026-11-17 | SEC EDGAR company profile | as filed | 2026-11-20 07:29 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-17 | SEC EDGAR company profile | as filed | 2026-11-20 07:29 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2025-12-31) | -$10,973,000 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-20 07:29 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31) | $2,000 | 2025-12-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | as filed | 2026-11-20 07:29 UTC | Report an error |
| Operating lease liabilities (at 2025-12-31) | $212,000 | 2025-12-31 | 10-K, XBRL OperatingLeaseLiability | as filed | 2026-11-20 07:29 UTC | Report an error |
| Form D total offering amount (D filed 2026-04-09) | $10,000,000 | 2026-04-09 | D | as filed | 2026-11-20 07:29 UTC | Report an error |
| Form D total amount sold (D filed 2026-04-09) | $9,999,929 | 2026-04-09 | D | as filed | 2026-11-20 07:29 UTC | Report an error |
| Form D industry group | Biotechnology | 2026-04-09 | D | as filed | 2026-11-20 07:29 UTC | Report an error |
| Form D revenue range | $1,000,001 - $5,000,000 | 2026-04-09 | D | as filed | 2026-11-20 07:29 UTC | Report an error |
| Form D date of first sale | 2026-03-20 | 2026-04-09 | D | as filed | 2026-11-20 07:29 UTC | Report an error |
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-05 · accession 0001193125-26-449910
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Revenue | $1,066,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-05 | 0001193125-26-449910 | 2026-11-20 07:29 UTC | Report an error |
| Net income (loss) | -$3,647,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-05 | 0001193125-26-449910 | 2026-11-20 07:29 UTC | Report an error |
| Cash and cash equivalents | $10,404,000 | at 2026-09-30 | 10-Q | 2026-11-05 | 0001193125-26-449910 | 2026-11-20 07:29 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-11-05 Filing 10-Q filed
- 2026-11-05 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-10-16 Filing RW filed
- 2026-08-20 Filing 8-K filed: Item 8.01 other event
- 2026-08-13 Filing 10-Q filed
- 2026-08-13 Filing 8-K/A filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-08-12 Filing 8-K filed: Item 9.01 exhibits
- 2026-08-04 Filing 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-07-02 Filing 8-K filed: Item 3.01 delisting notice
- 2026-06-30 Filing S-8 filed
- 2026-06-30 Filing 8-K filed: Item 5.07 shareholder vote; Item 9.01 exhibits
- 2026-05-15 Filing 10-K/A filed
- 2026-05-14 Filing 10-Q filed
- 2026-05-14 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-04-30 Filing DEF 14A filed
- 2026-04-27 Filing EFFECT filed
- 2026-04-27 Filing 424B3 filed
- 2026-04-23 Filing CORRESP filed
- 2026-04-22 Filing UPLOAD filed
- 2026-04-16 Filing S-3 filed
- 2026-04-09 Filing D filed
- 2026-03-31 Filing S-8 filed
- 2026-03-30 Filing 8-K filed: Item 2.02 results of operations; Item 8.01 other event; Item 9.01 exhibits
- 2026-03-30 Filing 10-K filed
- 2026-03-27 Filing 8-K filed: Item 5.02 officer or director change; Item 9.01 exhibits
8-K item text, as filed (excerpts)
- 2026-11-05 8-K Item 2.02
Results of Operations and Financial Condition. On November 5, 2026, RenovoRx, Inc. issued a press release announcing its financial results as of and for the quarter ended September 30, 2026. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. the 8-K · retrieved 2026-11-20 07:29 UTC - 2026-08-13 8-K Item 2.02
Results of Operations and Financial Condition. On August 12, 2026, RenovoRx, Inc. issued a press release announcing its financial results as of and for the quarter ended June 30, 2026. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. the 8-K · retrieved 2026-11-20 07:29 UTC
Each excerpt is the first part of the item's own text, copied as filed and cut at a word; the filing has the rest.
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | AIGH Capital Management LLC | $4,317,330 | 2026-06-30 | SEC 13F filing | 2026-11-20 07:29 UTC | Report an error |
| 2 | Bleichroeder LP | $1,632,776 | 2026-06-30 | SEC 13F filing | 2026-11-20 07:29 UTC | Report an error |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | $1,414,867 | 2026-06-30 | SEC 13F filing | 2026-11-20 07:29 UTC | Report an error |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | $415,687 | 2026-06-30 | SEC 13F filing | 2026-11-20 07:29 UTC | Report an error |
| 5 | Wealthspire Advisors, LLC | $247,475 | 2026-06-30 | SEC 13F filing | 2026-11-20 07:29 UTC | Report an error |
| 6 | VANGUARD FIDUCIARY TRUST CO | $235,523 | 2026-06-30 | SEC 13F filing | 2026-11-20 07:29 UTC | Report an error |
| 7 | CITADEL ADVISORS LLC | $130,925 | 2026-06-30 | SEC 13F filing | 2026-11-20 07:29 UTC | Report an error |
| 8 | NORTHERN TRUST CORP | $83,503 | 2026-06-30 | SEC 13F filing | 2026-11-20 07:29 UTC | Report an error |
| 9 | Chicago Partners Investment Group LLC | $78,918 | 2026-06-30 | SEC 13F filing | 2026-11-20 07:29 UTC | Report an error |
| 10 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $73,104 | 2026-06-30 | SEC 13F filing | 2026-11-20 07:29 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS13. Permits and local records
1 state and city record carry this company's exact name, from 1 source. Possible matches only.
ClinicalTrials.gov (1)
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/1574094.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001574094. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.